diabar news
01Jan

Plasma Collection and Processing Laboratory

The Dow Institute for Advanced Biological and Animal Research (DIABAR) is thrilled to announce the inauguration of its new facility, the Plasma Collection and Processing Laboratory (PCPL), a leading BMS-based Basic Biological Manufacturing Facility in the country. The inauguration took place on Friday, December 20th,...
14Oct

DIABAR showcases in Exhibitions

DIABAR participated, won awards/prizes in various national and international conferences and represented the DUHS as a hub of research to enhance the university scope.Travel Grant awarded for the IUIS 2023: 18TH International Congress of Immunology, Cape Town, South Asia, to present the project entitled;⦁ Polyacrilonytrile...
14Oct

Launching of DOW RAB (Anti-rabies Vaccine)

On March 13, 2024, DOWRAB, an anti-rabies vaccine developed by Dow University of Health Sciences, was officially launched, marking a significant milestone. The ceremony, attended by the Honorable Vice Chancellor, Prof. Mohammed Saeed Quraishy T.I., marked the start of a new era in the fight...
14Oct

DIABAR’s commitment towards the research and innovation

DIABAR is committed to publish quality research in esteemed journals, represent the institute at national and international forums and to conduct innovative research to address the national challenges. The number of articles during the year 2019-2023 is more than 18 publications in national and international...